Patient baseline characteristics by intervention and comparison groups
| Characteristics | Group 1 (pharmacist intervention) | Group 2 (preintervention comparison group) | Group 3 (concurrent comparison group) | Total all groups | SMD |
| n=1569 | n=873 | n=940 | N=3382 | ||
| Age | 0.067 | ||||
| Median (IQR) | 63 (51–73) | 61 (50–72) | 63 (53–73) | 62 (51–73) | |
| Race/ethnicity, n (%) | 0.117 | ||||
| Hispanic | 58 (3.7) | 19 (2.2) | 42 (4.5) | 119 (3.5) | |
| Non-Hispanic black | 793 (50.5) | 428 (49.0) | 440 (46.8) | 1661 (49.1) | |
| Non-Hispanic white | 664 (42.3) | 400 (45.8) | 416 (44.3) | 1480 (43.8) | |
| Other/unknown | 54 (3.4) | 26 (3.0) | 42 (4.5) | 122 (3.6) | |
| Sex, n (%) | 0.049 | ||||
| Female | 810 (51.6) | 463 (53.0) | 464 (49.4) | 1737 (51.4) | |
| Male | 759 (48.4) | 410 (47.0) | 476 (50.6) | 1645 (48.6) | |
| Length of stay | 0.044 | ||||
| Median (IQR) | 6.6 (3.6–13.2) | 6.1 (3.4–11.1) | 5.9 (3.2–11.5) | 6.2 (3.5–12) | |
| Discharge disposition, n (%) | 0.077 | ||||
| Facility | 594 (37.9) | 290 (33.2) | 304 (32.3) | 1188 (35.1) | |
| Home | 975 (62.1) | 583 (66.8) | 636 (67.7) | 2194 (64.9) | |
| Insurance status, n (%) | |||||
| Medicaid | 279 (17.8) | 154 (17.6) | 136 (14.5) | 569 (16.8) | 0.085 |
| Medicare | 1085 (69.2) | 618 (70.8) | 681 (72.4) | 2384 (70.5) | |
| Private | 145 (9.2) | 71 (8.1) | 94 (10.0) | 310 (9.2) | |
| Other/unknown | 60 (3.8) | 30 (3.4) | 29 (3.1) | 119 (3.5) | |
| Average risk score at discharge | 38.8 | 36.5 | 34.8 | 37.1 | 0.212 |
SMD, standardised mean difference.